Skip to content

SCI Pain App Intervention Study

SCI Pain App Intervention Study

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04818814
Enrollment
11
Registered
2021-03-26
Start date
2021-10-04
Completion date
2022-02-28
Last updated
2022-04-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Pain, Spinal Cord Injuries

Brief summary

The purpose of this study is to find out if using an app is a feasible and acceptable treatment for chronic pain in persons with spinal cord injury. Participants will have a 50% chance of being asked to listen to 10 minutes of audio-guided meditations using an app each day for six weeks, and a 50% chance of being asked to listen to 10 minutes of engaging and distracting presentations about topics of interest to the individual (TED Talks) for six weeks. All participants will be asked to complete three online surveys about their emotional and physical health lasting 20-30 minutes (one when the participant first enters the study, one six weeks later, and another six weeks later). Additionally, participants will be asked to complete brief (\<5 minute) online surveys once a week during the first six weeks of their participation. Participation in this study is very low risk, and participants may not experience any personal benefit from their participation. Participation in this study is entirely voluntary.

Interventions

BEHAVIORALMindfulness Meditation App

Listening to audio-guided meditation sessions using a mobile app.

BEHAVIORALEngagement and Distraction App

Listening to engaging and distracting videos of interest to the participant using a mobile app.

Sponsors

The University of Texas Health Science Center, Houston
CollaboratorOTHER
TIRR Memorial Hermann
CollaboratorOTHER
Baylor College of Medicine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. are at least 18 years of age 2. have a traumatic SCI of at least 6 months duration 3. have chronic pain \[defined as pain lasting at least 3 months with a pain intensity rating of 4 or higher on a 10-point visual analog scale\] 4. understand spoken and written English sufficiently to understand the goals, procedures, time involved, and the time involved in participation, participate in the intervention and complete study surveys.

Exclusion criteria

1. have a significant visual or hearing impairment that limits their ability to participate in the app/computer-based intervention 2. lack access to and the ability to use a smart phone or smart tablet (e.g., iPad) 3. are unable to provide or obtain an email address for communication 4. practiced any kind of meditation more than once a week in the past 3 months

Design outcomes

Primary

MeasureTime frameDescription
Feasibility of 6-Week Follow-Up Assessment as assessed by the proportion of participants who complete 6 weeks post-intervention follow up assessment6 weeks post-intervention (i.e., 12-weeks post-baseline)proportion of participants who complete 6 weeks post-intervention follow up assessment
Participant Satisfaction as assessed by a satisfaction questionnaire adapted from the Client Satisfaction Questionnaire for Internet-based Interventions (CSQ-I)Immediately post-intervention (i.e., 6-weeks post-baseline)participant reported satisfaction with their assigned condition; scores range from 12-48, with higher scores indicating greater satisfaction
Feasibility of Daily Practice as assessed by the proportion of assigned home practice completedImmediately post-intervention (i.e., 6-weeks post-baseline)proportion of assigned home practice completed by participants
Feasibility of Immediate Post-Intervention Follow-Up Assessment as assessed by the proportion of participants who complete immediate post-intervention follow up assessmentImmediately post-intervention (i.e., 6-weeks post-baseline)proportion of participants who complete immediate post-intervention follow up assessment

Secondary

MeasureTime frameDescription
Patient Health Questionnaire-8 itemImmediately post-intervention (i.e., 6-weeks post-baseline) and 6 weeks post-intervention (i.e., 12-weeks post-baseline)Depressive Symptoms; scores range from 0-24 with higher scores indicating greater depression symptoms
SCI-QOL Positive Affect and Wellbeing QuestionnaireImmediately post-intervention (i.e., 6-weeks post-baseline) and 6 weeks post-intervention (i.e., 12-weeks post-baseline)Self-reported Quality of Life; scores range from 10-50 with higher scores indicating greater quality of life
Generalized Anxiety Disorder Questionnaire-7Immediately post-intervention (i.e., 6-weeks post-baseline) and 6 weeks post-intervention (i.e., 12-weeks post-baseline)Anxiety Symptoms; scores range from 0-21 with higher scores indicating greater anxiety symptoms
International SCI Pain Basic Data Subset QuestionnaireImmediately post-intervention (i.e., 6-weeks post-baseline) and 6 weeks post-intervention (i.e., 12-weeks post-baseline)Self-reported pain intensity and interference on a 0-10 scale with higher scores indicating greater pain intensity and interference
Chronic Pain Acceptance QuestionnaireImmediately post-intervention (i.e., 6-weeks post-baseline) and 6 weeks post-intervention (i.e., 12-weeks post-baseline)Self-reported acceptance of pain; scores range from 0-156 with higher scores indicating greater acceptance of pain
Five Facet Mindfulness Questionnaire-Short FormImmediately post-intervention (i.e., 6-weeks post-baseline) and 6 weeks post-intervention (i.e., 12-weeks post-baseline)Self-reported mindfulness; scores range from 24-120 with higher scores indicating greater mindfulness

Other

MeasureTime frameDescription
Patient Health Questionnaire-2 itemAssessed weekly during the 6-week interventionDepressive Symptoms; scores range from 0-6 with higher scores indicating greater depression symptoms
Generalized Anxiety Disorder Questionnaire-2Assessed weekly during the 6-week interventionAnxiety Symptoms; scores range from 0-6 with higher scores indicating greater anxiety symptoms

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026